Completed OBSERVATIONAL NCT00302848

European Active Surveillance Study (EURAS)

The European Active Surveillance Study on OC Prescribing Practice, Benefits and Safety (EURAS)

Sponsor: Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Interventions Drospirenone Levonorgestrel Other progestin containing oral contraceptive

Updated 9 times since 2017 Last updated: Nov 6, 2009 Started: Nov 30, 2000 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Contraception, this trial is completed. The trial is conducted by Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma and has accumulated 9 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Dec 2021 — Dec 2022 [monthly]

Completed

▶ Show 4 earlier versions

Jan 2021 — Dec 2021 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE4 → None
Jan 2017 — Apr 2018 [monthly]

Completed PHASE4

First recorded

Nov 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Center for Epidemiology and Health Research, Germany

Data source: Center for Epidemiology and Health Research, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Berlin, Germany